(Q33338538)

English

Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma (English)

1 reference

Europe PubMed Central

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

White SC

1

1 reference

Europe PubMed Central

25 July 2017

Lorigan P

2

1 reference

Europe PubMed Central

25 July 2017

Middleton MR

3

1 reference

Europe PubMed Central

25 July 2017

Anderson H

4

1 reference

Europe PubMed Central

25 July 2017

Valle J

5

1 reference

Europe PubMed Central

25 July 2017

Summers Y

6

1 reference

Europe PubMed Central

25 July 2017

Burt PA

7

1 reference

Europe PubMed Central

25 July 2017

Arance A

8

1 reference

Europe PubMed Central

25 July 2017

Stout R

9

1 reference

Europe PubMed Central

25 July 2017

Thatcher N

10

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

92

1 reference

Europe PubMed Central

25 July 2017

3

1 reference

Europe PubMed Central

25 July 2017

601-608

1 reference

Europe PubMed Central

25 July 2017

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010801%2992%3A3%3C601%3A%3AAID-CNCR1360%3E3.0.CO%3B2-K

21 January 2018

Identifiers

10.1002/1097-0142(20010801)92:3<601::AID-CNCR1360>3.0.CO;2-K

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33338538&oldid=2038973069"